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Chapter 1: Introduction 
    Electron paramagnetic resonance (EPR)1 is a spectroscopic technique that detects species that 
have unpaired electron such as a nitroxide spin probe. With development of EPR spectroscopy, its 
application in biological studies has received a lot of attention and many potential applications of 
EPR imaging to studies of living system have been recognized. In my opinion, EPR may become the 
most promising brain imaging tool for understanding brain diseases progression and drug 
pharmacokinetics in the future. However, the lack of available stable spin probes is a major 
obstruction to successful and useful biological applications. 
    Nitoxide radicals have been widely used in many filed of EPR studies.2,3 However, fast 
reduction of nitroxide radicals to the corresponding hydroxylamines in vivo by antioxidants, such as 
ascorbic acid (AsA) or enzymatic systems, limited their application in biological studies.4,5 Since 
this kind of bioreduction is especially fast in brain, development of EPR spin probes for brain 
imaging has significant meaning. EPR spin probes for brain imaging require two basic properties 
including being blood-brain barrier (BBB) permeable and having sufficient stability in the brain. To 
date, very few nitroxides meet these qualifications. Moreover, spin probes for imaging of specific 
receptors in brain is a bigger challenge and no research on this area has been reported yet. Because 
those functional spin probes not only must meet these basic properties, but also have to bind to the 
target receptors that ligands or pharmaceutical drugs bind to. Considering of the significance to EPR 
imaging, the present thesis will focus on the development of spin probes for brain imaging. 
 
Chapter 2. Isotope Labeled Nitroxide Radical Probe for EPR Imaging 
    This chapter contained two parts. First, I focused on chiral spin probes for simultaneous EPR 
imaging.6 The 
simultaneous EPR 
imaging approach 
based on the different 
EPR spectra of isotopic 
nitrogen of the 
nitroxide radical. This 
approach has great 
potential to apply to 
visualize the distribution of target molecules, such as nitroxide labeled drugs. 
3-Hydroxylmethyl-2,2,5,5,-tetramethylpyrrolidine-1-oxyl (HMP) is a commonly used BBB 
 
Scheme 1 Synthesis of (S)-HMP-14N and (R)-HMP-15N 
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permeable nitroxide radial that has a chiral carbon. Thus, I prepared S snd R configurations of HMP 
for simultaneous EPR imaging. The synthesized route has been shown in Scheme 1. The sample 
tubes that contained both (S)-HMP-14N and (R)-HMP-15N were visualized at the same time using the 
method of simultaneous EPR imaging.7  
    Second, I focused on the synthesis of 
stable spin probe (15N-TEEPONE, 8) for 
brain imaging by EPR.8 In fact, many efforts 
have been made to improve the stability of 
nitroxides toward bioreduction by varying 
the steric and electronic environments 
around the N−O moiety.9,10 For example, 
4-oxo-2,2,6,6-tetraethylpiperidine nitroxide 
(TEEPONE, 6) is the most promising probe 
with respect to its resistance to AsA 
degradation. In EPR and magnetic resonance 
imaging of mouse brains, TEEPONE 
showed a remarkably long in vivo half life of 
greater than 80 min.11,12 While TEEPONE 
exhibits good resistivity to bioreduction in in 
vivo systems, a higher signal intensity is 
desirable for EPR imaging with a better 
signal-to-noise (S/N) ratio. Therefore, to 
fulfill this condition, 15N-labeling of 
TEEPONE was performed in this chapter. I 
presented a developed scalable synthesis of 
15N-4-oxo-2,2,6,6-tetraethylpiperidine 
nitroxide (15N-TEEPONE, 8) as shown in 
Scheme 2, and its first use for the brain 
imaging of mice. A comparison of 
15N-TEEPONE and 14N-TEEPONE was 
performed in mouse brain imaging. 15N-TEEPONE exhibited an in vivo spectrum with a better S/N 
ratio in a mouse head than 14N-TEEPONE. As shown in Figure 1, the distributions of the spin probes 
in mouse heads were also observed via 3-dimensional (3D)-EPR imaging and the 2D-slice-selective 
 
Scheme 2. Synthesis of 14N-TEEPONE and 15N-TEEPONE. 
(a) 3-pentanone (1.1 equiv), Zn (1.5 equiv), I2 (cat.), 
Et2O/PhH (3:1), rt, 30 min; (b) 3-pentanone (1 equiv), NaH 
(1.2 equiv), Et2O, rt, overnight, 52% over two steps; (c) 
AgOTf (0.1 equiv), DIPEA (1.0 equiv), CO2 (3 atm), 
CH2Cl2, rt, 24 h, 83%; (d) conc. H2SO4 (cat.), CHCl3, 60 oC, 
1 h, 80%; (e) NH4Cl (6.5 equiv), KOH (6.5 equiv), 
EtOH/H2O (3:4), sealed tube, 3 days, 40% (73% brsm); (e’) 
15NH4Cl (6.5 equiv), KOH (6.5 equiv), EtOH/H2O (3:4), 
sealed tube, 3 days (f) Na2WO4·2H2O (0.29 equiv), H2O2 
(6.0 equiv), H2O/MeOH (3:1), 80% for 6 and 8.  
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images are depicted in Figures 1C. These images show that TEEPONE and 15N-TEEPONE were 
distributed in the mouse brain. However, the sensitivity of the instrument did not allow the 
monitoring of the 14N-TEEPONE signals for such a long period under these conditions (see the 
single time-point images in Figure 1C). In contrast, 15N-TEEPONE signals were successfully 
observed even at 1 h after the injection (Figure 1C). As a result, 15N-TEEPONE was detectable for a 
longer time during in vivo EPR analysis, even though 15N-TEEPONE and 14N-TEEPONE have 
similar half lives. In addition, 15N-TEEPONE in combination with 14N-TEEPONE has great 
potential as a spin label precursor for use in simultaneous EPR imaging techniques. 
 
  
          
 
 
Figure 1. EPR imaging of mouse heads with injected 15N-TEEPONE and 14N-TEEPONE. The mice were 
anesthetized with isoflurane (1.5%). The EPR spectra were collected after probe injection, and the images were 
reconstructed from the spectra using the filtered back-projection method. (A) Photograph of a mouse head. (B) 
MRI image of an examined mouse head. (C) 3D-EPR images and 2D slice-selective images of mouse heads. EPR 
images were obtained at the indicated time after the injection. 15N-TEEPONE (upper) and 14N-TEEPONE 
(lower). *12 sets of EPR images were accumulated. 
 
 
Chapter 3. Design and Synthesis of Brain Imaging Spin Probes for EPR Imaging of Mouse 
Brain 
    The nicotine acetylcholine receptors (nAChRs) are widely distributed throughout the central 
and peripheral nervous systems, where mediate 
a variety of brain function. Central nervous 
diseases, such as Alzheimer’s disease, have 
been associated with changes in nAChRs.13 It 
suggests that imaging of nAChRs might 
provide valuable in vivo information in the 
early course of the disease and on the efficacy 
of treatment. Considering the role of nAChR in 
the pathophysiology of Alzheimer’s disease, it 
is of great interest to study nAChR in brain of 
living object. Thus I designed and synthesized a 
series of spin probes (Figure. 2) for EPR brain 
imaging by using nAChRs ligands, 
3-pyridyl-ether compounds,14 which generally 
possess subnanomolar affinity for brain 
nAChRs. The first generation spin probe 
(G1-S-probe) was not BBB permeable. To 
overcome this problem, the second generation 
of spin probes (G2-S-probe and G2-R-probe), 
which have lower molecular weight and higher 
lipophilicity, were synthesized. The results of 
mouse brain in vivo EPR imaging (Figure 3A, 
B) indicated that G2-S-probe and G2-R-probe 
were BBB-permeable, and the highest signal 
intensities were found in thalamusthe and 
colliculus regions of mouse brain was similar to 
that of the radiolabeled trace 5-[125I]-A-85380 
for nAChRs by PET.15 The distributions of 
G2-S-probe and G2-R-probe in mouse heads 
 
Fig. 2 Chemical structures of synthesized spin probes  
for EPR imaging of nAChRs 
 
 
Figure. 3 EPR imaging of mouse heads with injected 
G2-S-probe and G2-R-probe. (A) Slice-selective EPR 
image of a mouse head with G2-S-probe; (B) 
Slice-selective EPR image of a mouse head with 
G2-R-probe (C) The EPR spectral signal ratio of 100 
mM (-)-nicotine added samples to non-added samples 
for G2-S-probe or G2-R-probe (N = 4). 
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have been confirmed from EPR imaging. However, these images are not enough to understand the 
relationship between spin probe to nAChRs. Therefore it is essential to illuminate whether 
synthesized spin probes specifically bind to nAChRs. Selectivity of G2-S-probe and G2-R-probe for 
nAChRs was determined by pretreating with (-)-nicotine and followed by administration of 
G2-S-probe or G2-R-probe. The binding interaction of probes to receptors would be inhibited by 
(-)-nicotine and result in changes of EPR signal intensities. In addition, the difference in binding 
affinities of two enantiomeic probes was clarified according to inhibition effect by nicotine. As 
showen in Figure 3C, the result of G2-S-probe (IS (100) / IS (0)) indicated (-)-nicotine competitively 
suppressed binding of G2-S-probe to the brain homogenate. While, in case of G2-R-probe, 
(-)-nicotine didn’t altered the binding of G2-R-probe to the brain homogenate. These results implied 
that G2-S-probe has specific binding affinity to nAChRs while G2-R-probe has not.  
    The second-generation 
spin probes were able to go 
through BBB in brain, and 
the difference of the R and 
S configuration to nAChRs 
binding was also confirmed. 
However, toxicity of those 
probes was a serious 
problem for animal 
experiments. An attempt 
(G3-S-probe) to avoid 
toxicity was the introduction of TEEPONE to probe instead of TEMPONE, but the broadened 
linewidth EPR spectrum were observed. In order to improve the sensitivity and resolution of EPR 
spectroscopy of biological problems, a perdeuterated spin probe derivative would be an option.16,17 
Therefore, the perdeuterated spin probe (G4-S-probe) will be synthesized in the future (Sheme 3). 
 
Chapter 4. Conclusion 
    First, two pairs of chiral nitroxide probes have been synthesized for the simultaneous EPR 
imaging. Importantly, I successfully synthesized 15N-TEEPONE and EPR results implied that 
15N-TEEPONE was suitable for EPR brain imaging, and its higher sensitivity is an important 
advantage for brain imaging studies. In order to study nAChRs in brain of living object, a series of 
spin probes were synthesized. Among them, G2-S-probe was successfully used as a spin probe for 
 
Scheme 3 Strategy of synthesis of perdeuterated spin probe (G4-S-probe). 
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brain imaging and its specific binding affinity to nAChRs was indicated. The G3-S-probe, an attempt 
to reduce the toxicity for animal experiments didn’t work. Thus, the work presented here is still in 
progress. I suggest that a perdeuterated spin probe derivative would be the next option because 
deuteration of the nitroxide moiety could narrowing EPR linewidth and therefore make reduced 
injection dose possible. 
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